Phenotypes of Postinjury Fibrinolysis : Hyperfibrinolysis, Physiologic

 EE Moore Denver Health / University of Colorado Denver Disclosure : Haemone;cs & TEM Research Support Fibrinolysis : Long History Many Question
•  John Hunter : 1794
–  Edinburgh … clinical observation
•  Albert Dastre : 1893
–  Paris … “fibrinolysis”
Physiologic Fibrinolysis
Systemic thrombin binds to a protease-­‐ac;vated receptor … with release of ;ssue plasminogen ac;vator ( tPA ) Pathologic Fibrinolysis
•  TEG detected
pathologic fibrinolysis
•  Empiric EACA during
anhepatic phase
Starzl et al
Surgery 1963
Thombelastography
Liver Transplantation … Pattern Recognition
3 / 4 Liver Transplant Survivors
EACA = Multiple Pulmonary Emboli
75% Mortality
“If treatment should become
necessary for a hemorrhagic
diathesis,
it should be guided by frequent
measures of clotting
parameters.”
Starzl et al
Arch Surg 1966
Physiologic vs Pathologic Fibrinolysis Apro;nin – Plasmin Inhibitor Blood Conserva;on using An;fibrinoly;cs in a Randomized Trial ( BART ) •  Myocardial Infarc;on •  Renal Failure •  Mortality 2008 Trauma Experience •  Brohi, Cohen 2007 •  Denver – 2009 TEG documented lysis •  Correla>on of fibrinolysis and death •  CRASH II trial CRASH-2 Trial : RCT / 274 Hospitals / 40 Countries
20,211
Adult
:
SBP < 90 or HR > 110, within 8 Hr
Tranexamic Acid 1 gm / 10 min + 1 gm / 8hr
Mortality : 14.5% vs 16.0% ( p < .04)
Death due to Bleeding : 4.9% vs 5.7% ( p < .08 )
BUT :
RR = 0.91
RR = 0.85
No Documented Fibrinolysis
Blood Transfusion … Only 50% of Patients
No Reduction in Transfusion ( ~ 6 Units RBC )
Lancet 2010
CRASH-2 Trial : RCT / 274 Hospitals / 40 Countries
RR < 1 hr = 0.68
RR 1-3 hr = 0.70
RR > 3hr = 1.44
Lancet 2011
Plasmin Effects Beyond Fibrinolysis
– Induces release of IL-1, TNF, and CD40
by peripheral monocytes ( similar to LPS )
–  Induces post-translational modifications to IL-8
increasing activity
–  Platelet activator via PAR-4
( bi-phasic response depending on concentration )
–  Proposed receptors in monocytes / macrophages
PAR-1, PAR-4, annexin-A2, TLR4, H2B
–  Cleaves complement C3 and C5
creating anaphylotoxins
J Thromb Haemostasis 2005
Fibrinolysis = Euglobulin Lysis Time
H4
Pooled Plasma 2.000
Absorbance (405 nm) 1.500
1.000
0.500
0.000
-0.500
0
120
240
360
480
600
Time
> 4 Hours to Perform
Time (minutes) Manco - Johnson
Thromb Res 2003
TEG & ROTEM
Early
Detection
Fibrinolysis
Postinjury Fibrinolysis : S/P MVC
Incidence of Postinjury Fibrinolysis
•  Denver = 2% Activations ( 17 % M Transfusion )
•  Houston = 2% Activations
•  Lyon
= 6% Activations
•  Salzburg = 8% Activations
•  Los Angeles
=
•  San Francisco =
( 10% M Transfusion )
( 20% M Transfusion )
Principal Component Analysis
Multivariate statistical technique that reduces the
number of variables of the dataset into a smaller
number of components.
TIC : Principal Component Analysis
Kutcher, Cohen et al
J Trauma 2013
TIC : Factor Depletion vs Fibrinolysis
PC 1
Surgery
2014
PC 2
PC 3
Eigenvalue
4.73
1.13
% Variance
59% 14% 12% ACT
74
*
-6
K
80
*
-26 5 18
angle
-96
*
-9 -12
MA
-92
*
-35 3
LY30
15 TMRTG
8 95
0.922
*
-3
-3 98
MRTG
-81
*
-25 -11
TTG
-90
*
-37 3
*
Physiologic vs Pathologic Fibrinolysis
Shock Enhances Fibrinolysis …
Tissue Injury Inhibits Fibrinolysis
Clinical Outcomes : Fibrinolysis
J Trauma
2014
Postinjury Spectrum of Fibrinolysis
PATHOLOGIC
N=156
( 71% )
PHYSIOLOGIC
N=37
( 19% )
HYPERFIBRINOLYSIS
N=33
( 17% )
Uncontrolled Bleeding
Mortality =
19 ( 58% )
Exsanguination
FIBRINOLYSIS
SHUTDOWN
Microvascular
Occlusion
Mortality =
20 ARDS/MOF
( 16% )
N=123
( 64% )
Maintenance
Fibrinolysis
Vascular Patency
Mortality =
1Homeostasis
( 3% )
Postinjury Spectrum of Fibrinolysis
12
10
Hemorrhage /CA
8
TBI
6
4
MOF/Sepsis
2
0
Hyper
Shutdown
Physiologic
Recent Trauma Experience in the US Fibrinolysis Regulation
Plasminogen
TXA
tPA
PAI- 1
Plasmin
Plasmin
Regulation
fibrin
fibrin
fibrin
Hyperfibrinolysis = PAI-­‐1 Deple;on Fibrinolysis Shutdown = Excessive PAI-1
Physiologic Vs Shutdown
TPA Challenge
Physiologic
LY30 1.7%
Shutdown
Ly30 0.5%
Lysed Red Blood Cells Enhance tPA Mediated Fibrinolysis
vs Lysed Platelets Shutdown tPA mediated Fibrinolysis
Red Blood Cell Lysate Indirectly Enhances tPA Mediated Fibrinolysis Platelet Lysate Directly Inhibits tPA Mediated Fibrinolysis Postinjury Hyperfibrinolysis
Hypoxia Gene;cs Co –Morbidity Medica;on Adrenaline • Dilu;on • Consump;on tPA Ac;vated Protein C
?
Histones Elastase HMGB1 Complement Tissue Factor Thrombin sThrombomodulin Heparan Sulfate sCD40L Endothelial Dysfunc;on • Acidosis • Hypothermia Tissue Injury Plasmin PAI-­‐1 FXIIIa
FibrinolysiS TRAUMA INDUCED COAGULOPATHY Conclusion
Antifibrinolytic Medication … Selective
– Majority of seriously injured = shutdown of fibrinolysis
But … Civilian Experience is Different from Military
Mechanisms of Fibrinolysis Warrant Further Investigation
Credits : UCD Trauma Research Team
Ani Banerjee
Kirk Hansen
Angela Sauaia
Chris Silliman
Mike Chapman
Theresa Chin
Eduardo Gonzalez
Hunter Moore
Max Wohlauer
Sarah Ammons
Jim Chandler
Andrea Emard
Cortney Fleming
Arsen Ghasabyan
Ray Shepard-Singh
NIH P50 GM 4922
NIH T32 GM 08315
NIH UM1 HL 129877
Thank you !!!
X
TF
Va
Xa
VIIa
IIa
VIII / vWF
VIIIa
TF-Bearing Cell
TF
VIIa
IXa
IX
IX
Xa
VIIIa
Platelet
VIIIa
Xa
X
IIa
Va
Activated Platelet
IXa
Va
II
X
IXa
VIIa
V
Va
IIa
TXA : Presumed Mechanism Lysine Aminocaproic acid Tranexamic acid Blocks fibrinogen to plasminogen / plasmin Inhibits alpha2-­‐an;plasmin to plasmin Experimental – Plasmin Activity
• Plasma –
30 minutes
• Liver -90 minutes
• Heart –
120 minutes
• Kidney - 30/60/90 :
120
TXA : Potential SAE
•  Thromboembolism Early : ? Pre-­‐exis;ng = Coronary Stent ? Injury = Caro;d / Vertebral Delayed : DVT / Pulmonary Embolism Cerebral Infarc;on • Seizures
S/P CABG – TXA Binds GABA Receptor •  Acute Kidney Injury •  Central Re;nal Artery Thrombosis Differen;al Inhibited FF-­‐TEG 100 ng/ml tPA in Whole Blood LY 30 DIFF-­‐TEG Detec;on Threshold for tPA is Superior to CK-­‐TEG DIFF-­‐TEG Improved Detec;on Threshold CK-­‐TEG Detec;on Threshold >2x Higher Rapid Detec;on of Fibrinolysis rTEG FF + TXA FF Field Blood – ELT analysis
600 500 ELT (minutes) Survived Death 400 300 200 100 0 0 0.5 1 1.5 2 2.5 LY30 (%) 3 3.5 4 4.5 5 Red Blood Cell Lysate Enhance tPA Mediated Fibrinolysis Red Blood Cell and Platelet Lysate Reduce Clotting Time Thrombelastography =
Early Identification of Fibrinolysis
EPL : Percent Lysis
Fibrinolysis
Viscoelastic Coagulation Assessment
r TEG
ROTEM
Tissue Factor + Kaolin
ACT
= 78 - 110 sec
INTEM ( Ellagic )
EXTEM ( TF )
CT
= 122 - 208
43 - 82
Angle = 66 - 82 degrees
Angle
=
70 - 81
65 - 80 degrees
MA
= 54 - 72 mm
MCF
=
51 - 72
52 – 70 mm
G
=
…..
< 15 %
< 15 %
LY30 =
5.3 - 12.4 dynes/cm
< 7.5 %
Functional Fibrinogen
ML
=
FIBTEM
APTEM
HEPTEM
sec
Amplilute ( mm )
Rapid Thrombelastography
ACT
ED Thoracotomy : SW LV … Prehospital CPR 11 min
Antifibrinolytic Agents
•  Aminocaproic Acid … lysine binding site plasminogen
•  Tranexamic Acid
… lysine binding site ( 10 X )
•  Aprotinin
… directly inhibits plasmin
( thrombotic complications )
Military : Tranexamic Acid (MATTERS)
Afghanistan : 2009 - 2011 US / UK
Random < 2010 > Routine MTP
TXA 1 gm, Repeat “Judgment”
Overall ( n = 896 )
MT ( n = 231 )
TXA None TXA None Cryo 1.6 0.5 1.6 0.7 DVT 2.4 0.2 3.2 0 PE 2.7 0.3 1.6 0.5 Mort -­‐ 24 10% 12% 10% 15% Mort -­‐ D/C 17% 24% 15% 28% Morrison et al
Arch Surg 2012
Hyperfibrinolysis Phenotypes
(A)  Fulminant HF … immediate breakdown of the clot (B) Intermediate HF … breakdown of the clot between 30 and 60 min. (C) Late HF … clot lysis aker more than 60 min. Schochl et al J Trauma 2009 Biomarker or Mediator
Johansson et al
J Trauma 2012
Plasminogen Activation ?
Physiologic vs Pathologic Fibrinolysis
Thromboelastometry (TEM) underes;mates the incidence and severity of fibrinolysis. Hyperfibrinolysis defined by func;onal lysis ROTEM ML > 15% Moderate = ML < 15% and PAP complex > 1500 μg L−1; Severe = ML > 15% and PAP complex > 1500 μg L−1) Func;onal clot lysis (dark bars) was only measurable with very high PAP complex levels ( PAP complex < 1500 μg L−1– 8.8% vs. PAP complex > 20 000 μg L−1– 30.3%). Raza, Brohi et al J Thrombo Haemostasis 2013 Physiologic vs Pathologic Fibrinolysis
Outcomes associated with moderate and severe fibrinolysis. Higher mortality … in the moderate group ( 12% ) and the severe group ( 40% ) Raza, Brohi et al J Thromb Haemostasis 2013 TEG vs ROTEM •  Blood from healthy volunteers •  tPA (100 ng/ml) added to one vial •  TEG (Tissue Factor, Kaolin, Func>onal Fibrinogen) and ROTEM (EXTEM, INTEM, FIBTEM) Normal tPA TEG LY 30 Threshold for
Hyperfibrinolysis
3%
Coqon, Holcomb et al J Trauma 2012 TIC : Principal Component Analysis
Kutcher, Cohen et al
J Trauma 2013
Role of Disseminated Intravascular Coagulation
Fibrinogen Controversies in Postinjury Hemostasis
X
TF
Va
Xa
VIIa
IIa
VIII / vWF
VIIIa
TF-Bearing Cell
TF
VIIa
IXa
IX
IX
Xa
VIIIa
Platelet
VIIIa
Xa
X
IIa
Va
Activated Platelet
IXa
Va
II
X
IXa
VIIa
V
Va
IIa